Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

106
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
106
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

58
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
58
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

102
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
102
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

65
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
65
Phase II Reactions: Acetylation Reactions01:24

Phase II Reactions: Acetylation Reactions

991
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
991
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

19.7K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic variation of <i>Enterobius vermicularis</i> among schoolchildren in Thailand.

Journal of helminthology·2018
Same author

Cloning and expression of enterovirus 71 capsid protein 1 in a probiotic Bifidobacterium pseudocatenulatum.

Letters in applied microbiology·2018
Same author

Genetic polymorphisms of CCL2 associated with susceptibility to latent tuberculous infection in Thailand.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2016
Same author

Haem oxygenase 1 expression is associated with prognosis in cholangiocarcinoma patients and with drug sensitivity in xenografted mice.

Cell proliferation·2016
Same author

Development of multiplex pyrosequencing for HLA-B*57:01 screening using single nucleotide polymorphism haplotype.

Journal of clinical pharmacy and therapeutics·2014
Same author

Molecular differentiation of Trichinella spiralis, T. pseudospiralis, T. papuae and T. zimbabwensis by pyrosequencing.

Journal of helminthology·2013

Related Experiment Video

Updated: Mar 21, 2026

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.4K

N-acetyltransferase polymorphism in Thailand.

V Kukongviriyapan, V Lulitanond, C Areejitranusorn

    Human Heredity
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    This study investigated acetylator phenotypes in Thai and Chinese populations. Results indicate a lower frequency of rapid acetylators in Thais compared to prior research.

    More Related Videos

    A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
    07:00

    A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

    Published on: April 1, 2019

    10.5K
    Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
    06:33

    Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

    Published on: June 9, 2018

    8.2K

    Related Experiment Videos

    Last Updated: Mar 21, 2026

    Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
    06:21

    Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

    Published on: May 10, 2024

    1.4K
    A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
    07:00

    A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

    Published on: April 1, 2019

    10.5K
    Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
    06:33

    Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

    Published on: June 9, 2018

    8.2K

    Area of Science:

    • Pharmacogenetics
    • Human genetics
    • Biochemistry

    Background:

    • Acetylator phenotype is a genetically determined trait influencing drug metabolism.
    • Variations in acetylator phenotypes exist across different ethnic groups.
    • Previous studies suggested specific frequencies for rapid acetylators in Thai populations.

    Purpose of the Study:

    • To determine the frequency of acetylator phenotypes in northeastern Thai individuals.
    • To compare acetylator phenotypes between Thai and Chinese populations.
    • To assess potential discrepancies with previous findings on Thai acetylator frequencies.

    Main Methods:

    • Phenotyping 222 individuals from northeastern Thailand.
    • Analyzing acetylator status (rapid vs. slow).
    • Statistical comparison between Thai and Chinese groups.

    Main Results:

    • 55.5% of pure Thai descent individuals were identified as rapid acetylators.
    • 66.0% of Chinese individuals were identified as rapid acetylators.
    • No significant differences were observed between Thai and Chinese acetylator phenotypes.

    Conclusions:

    • The observed frequency of rapid acetylators in Thais is lower than previously reported.
    • Thai and Chinese populations exhibit similar acetylator phenotype distributions.
    • Further research may be needed to clarify regional and ethnic variations in acetylator phenotypes.